Transaction · 0001127602-25-005525

Dickinson Andrew D

Dickinson Andrew D, CFO, reported an open-market or private sale at GILEAD SCIENCES, INC. involving 2500.000000 shares for an estimated $260225.00. Reported holdings after the transaction were 169061.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCFO
GILDGILEAD SCIENCES, INC.
Filing timeFeb 19
Trade dateFeb 18, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

GILD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
GILD since 2025-02-19Filed 561 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001127602-25-005525
Common Stock
Transaction date
Feb 18, 2025
Filed Feb 19, 2025, 09:43 PM · 1d delay
Shares
2.50k sh
$10.4k per share
Estimated value
-$26.0M
Computed from shares × price
Holdings after
169k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.

  2. F2

    Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.

Original filing · 0001127602-25-005525
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

GILD